QB3 is the University of California’s hub for innovation and entrepreneurship in the life sciences. The institute supports UC researchers and empowers Bay Area entrepreneurs to launch startup companies and partner with industry. With five incubators, two seed-stage venture capital firms, and a special initiative in medical devices — the Rosenman Institute — QB3 helps bio-entrepreneurs create high-value jobs and brings more than $750 million into the Bay Area each year.
QB3 unites quantitative, biological, biomedical, and structural scientists at three University of California campuses — Berkeley, San Francisco, and Santa Cruz — with private industry collaborators to address problems concerning human health. QB3 aims to harness the quantitative sciences to integrate our understanding of biological systems at all levels of complexity — from atoms and protein molecules to cells, tissues, organs, and the entire organism. QB3 scientists attack problems that have been simply unapproachable before, setting the stage for fundamental new discoveries, new products, and new technologies.
